Results 91 to 100 of about 2,106 (148)

Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study. [PDF]

Pharmacogenomics J
Görnert C, Scherf-Clavel M, Weber H, Roll SC, Eckert A, Reif A, Hahn M.   +6 more
europepmc   +1 more source

Impact of CYP2D6 Genotype and Inhibitor Use on Risperidone Metabolism in Children: Functional Insights Into the *17 and *29 Alleles. [PDF]

Clin Transl Sci
Bennett MH, Poweleit EA, Vaughn SE, Retke B, Toren P, Strawn JR, Ramsey LB.   +6 more
europepmc   +1 more source

Design considerations for C9orf72 disease prevention trials. [PDF]

Brain
Benatar M, Staffaroni AM, Wuu J, McDermott MP, Quintana M, Swidler J, Andersen G, Huey ED, Turner MR, Macklin EA, Berry JD, McMillan CT, Gendron T, Onyike C, Rosen H, Heuer HW, Grignon AL, Dave KD, Balas C, Gleixner A, Satlin A, Dunn B, Dacks P, Boxer AL.   +23 more
europepmc   +1 more source

Cholinergic degeneration in prodromal and early Parkinson's disease: a link to present and future disease states. [PDF]

Brain
Eisenstein T, Groenewald K, van Hillegondsberg L, Al Hajraf F, Zerenner T, Lawton MA, Ben-Shlomo Y, Griffanti L, Hu MT, Klein JC.   +9 more
europepmc   +1 more source

Blood will tell: plasma biomarkers in isolated REM sleep behavior disorder. [PDF]

Sleep
Ibrahim A, Süzgün MA, Stefani A.
europepmc   +1 more source

Susceptibility and diffusion MRI biomarkers predict development of Parkinsonism in iRBD. [PDF]

NPJ Parkinsons Dis
Varga Z, Nepozitek J, Hlavnicka J, Keller J, Ojha A, Pantano P, Marecek S, Sonka K, Dusek P.   +8 more
europepmc   +1 more source

CYP2D6 Phenotype as a Predictor of Adverse Drug Reactions in Patients Treated With Trazodone: An Explorative Pharmacogenetic Study. [PDF]

J Clin Psychopharmacol
Wiss FM, Krieg CD, Lampert ML, Meyer Zu Schwabedissen HE, Stäuble CK, Mikoteit T, Imboden C, Allemann SS.   +7 more
europepmc   +1 more source

The Syn-Q study: detection of cutaneous phosphorylated alpha-synuclein in Parkinson's disease progression: a trial protocol. [PDF]

Front Neurol
Parent JH, Levine T, Freeman R, Gibbons CH.   +3 more
europepmc   +1 more source

The role of tissue-based biomarkers in isolated REM sleep behavior disorder: implications for early detection and prognostication. [PDF]

Sleep
Baumgartner AJ, Amara AW.
europepmc   +1 more source

REM Sleep Behavior Disorder as a Prodromal Synucleinopathy: Updates on Clinical and Laboratory Biomarkers, and Implications for Neuroprotective Trials. [PDF]

Curr Neurol Neurosci Rep
Neilson LE, Khattab YI, Lim MM.
europepmc   +1 more source